Helixmith ranked among the top searched stocks on 2 days within the past month.
As of 2:31 PM on the 17th, Helixmith is trading at 52,400 KRW, down 4.9% from the previous day. This represents a 14.29% increase compared to September 4. Helixmith is known as a specialized company developing new drugs focused on gene therapy.
Today, foreigners are tentatively recorded as net buyers of 3,000 shares. Over the past 5 days, individual investors have net purchased 235,533 shares, while foreigners and institutions have net sold 219,934 shares and 26,225 shares, respectively.
On September 16, Helixmith became a market issue with a 9.7% increase following the news of submitting a gene therapy clinical trial plan to the FDA.


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
